{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T12:52:57Z","timestamp":1787662377431,"version":"build-2736575974"},"reference-count":149,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.lfs.2019.117080","type":"journal-article","created":{"date-parts":[[2019,11,19]],"date-time":"2019-11-19T11:16:14Z","timestamp":1574162174000},"page":"117080","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"special_numbering":"C","title":["Angiopoietin 2 signal complexity in cardiovascular disease and cancer"],"prefix":"10.1016","volume":"239","author":[{"given":"Giuseppina","family":"Nicolini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Forini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Kusmic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Iervasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvana","family":"Balzan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2019.117080_bb0005","doi-asserted-by":"crossref","DOI":"10.3390\/cells8050471","article-title":"Role of angiopoietin-2 in vascular physiology and pathophysiology","volume":"8","author":"Akwii","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.lfs.2019.117080_bb0010","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1042\/CS20160129","article-title":"Angiopoietin\u2013Tie signalling in the cardiovascular and lymphatic systems","volume":"131","author":"Eklund","year":"2017","journal-title":"Clin. Sci."},{"key":"10.1016\/j.lfs.2019.117080_bb0015","doi-asserted-by":"crossref","first-page":"a009183","DOI":"10.1101\/cshperspect.a009183","article-title":"Receptor tyrosine kinase-mediated angiogenesis","volume":"5","author":"Jeltsch","year":"2013","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.lfs.2019.117080_bb0020","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/nrm2639","article-title":"Control of vascular morphogenesis and homeostasis through the angiopoietin-Tie system","volume":"10","author":"Augstin","year":"2009","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.lfs.2019.117080_bb0025","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/S0092-8674(00)81812-7","article-title":"Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning","volume":"87","author":"Davis","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.lfs.2019.117080_bb0030","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/S0092-8674(00)81813-9","article-title":"Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis","volume":"87","author":"Suri","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.lfs.2019.117080_bb0035","doi-asserted-by":"crossref","first-page":"a006650","DOI":"10.1101\/cshperspect.a006650","article-title":"The complex role of Angiopoietin-2 in the Angiopoietin\u2013Tie signaling pathway","volume":"2","author":"Thurston","year":"2012","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.lfs.2019.117080_bb0040","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.molmed.2012.10.010","article-title":"Orchestral actions of angiopoietin-1 in vascular regeneration","volume":"19","author":"Koh","year":"2013","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.lfs.2019.117080_bb0045","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/ncb1715","article-title":"Angiopoietins assemble distinct Tie2 signalling complexes in endothelial cell-cell and cell-matrix contacts","volume":"10","author":"Saharinen","year":"2008","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.lfs.2019.117080_bb0050","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1126\/science.277.5322.55","article-title":"Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis","volume":"277","author":"Maisonpierre","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.lfs.2019.117080_bb0055","doi-asserted-by":"crossref","first-page":"4150","DOI":"10.1182\/blood-2003-10-3685","article-title":"The Tie-2 ligand angiopoietin-2 is stored in and rapidly released upon stimulation from endothelial cell Weibel-Palade bodies","volume":"103","author":"Fiedler","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.lfs.2019.117080_bb0060","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.it.2006.10.004","article-title":"Angiopoietins: a link between angiogenesis and inflammation","volume":"27","author":"Fiedler","year":"2006","journal-title":"Trends Immunol."},{"key":"10.1016\/j.lfs.2019.117080_bb0065","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1161\/01.RES.83.8.852","article-title":"Regulation of angiopoietin-2 mRNA levels in bovine microvascular endothelial cells by cytokines and hypoxia","volume":"83","author":"Mandriota","year":"1998","journal-title":"Circ. Res."},{"key":"10.1016\/j.lfs.2019.117080_bb0070","doi-asserted-by":"crossref","first-page":"H187","DOI":"10.1152\/ajpheart.01058.2003","article-title":"Dual functional roles of Tie-2\/angiopoietin in TNF-alpha-mediated angiogenesis","volume":"287","author":"Chen","year":"2004","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.lfs.2019.117080_bb0075","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1161\/01.RES.86.1.24","article-title":"Angiopoietin-1 regulates endothelial cell survival through the phosphatidylinositol 3\u2019-kinase\/Akt signal transduction pathway","volume":"86","author":"Kim","year":"2000","journal-title":"Circ. Res."},{"key":"10.1016\/j.lfs.2019.117080_bb0080","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1182\/blood.V99.5.1646","article-title":"Thrombin induces increased expression and secretion of angiopoietin-2 from human umbilical vein endothelial cells","volume":"99","author":"Huang","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.lfs.2019.117080_bb0085","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1111\/jth.13376","article-title":"Angiopoietin-2 mediates thrombin-induced monocyte adhesion and endothelial permeability","volume":"14","author":"Rathnakumar","year":"2016","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.lfs.2019.117080_bb0090","doi-asserted-by":"crossref","unstructured":"Zhang J., Fan G., Zhao H., Wang Z., Li F., Zhang P., et al., Targeted inhibition of Focal Adhesion Kinase Attenuates Cardiac Fibrosis and Preserves Heart Function in Adverse Cardiac Remodeling, Sci. Rep. 7 (2017) 43146. doi: https:\/\/doi.org\/10.1038\/srep43146.","DOI":"10.1038\/srep43146"},{"key":"10.1016\/j.lfs.2019.117080_bb0095","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1038\/nrc3792","article-title":"FAK in cancer: mechanistic findings and clinical applications","volume":"14","author":"Sulzmaier","year":"2014","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.lfs.2019.117080_bb0100","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1158\/0008-5472.CAN-12-2064","article-title":"Angiopoietin-2 functions as a Tie2 agonist in tumor models, where it limits the effects of VEGF inhibition","volume":"73","author":"Daly","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.lfs.2019.117080_bb0105","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.jacc.2003.08.042","article-title":"Plasma angiopoietin-1, angiopoietin-2, and angiopoietin receptor tie-2 levels in congestive heart failure","volume":"43","author":"Chong","year":"2004","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.lfs.2019.117080_bb0110","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1097\/CCM.0b013e318241e34e","article-title":"Angiopoietin-2 in acute liver failure","volume":"40","author":"Hadem","year":"2012","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.lfs.2019.117080_bb0115","doi-asserted-by":"crossref","first-page":"211","DOI":"10.2169\/internalmedicine.47.0423","article-title":"Nutritional and prognostic significance of sick euthyroid syndrome in non-small cell lung cancer patients","volume":"47","author":"Cengiz","year":"2008","journal-title":"Intern. Med."},{"key":"10.1016\/j.lfs.2019.117080_bb0120","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/bjh.14528","article-title":"Low T3 syndrome is a strong prognostic predictor in diffuse large B cell lymphoma","volume":"177","author":"Gao","year":"2017","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.lfs.2019.117080_bb0125","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1186\/1471-2407-13-334","article-title":"Implication from thyroid function decreasing during chemotherapy in breast cancer patients: chemosensitization role of triiodothyronine","volume":"13","author":"Huang","year":"2013","journal-title":"BMC Cancer"},{"key":"10.1016\/j.lfs.2019.117080_bb0130","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1210\/jcem.82.5.3939","article-title":"Elevated 3,5-diiodothyronine concentrations in the sera of patients with nonthyroidal illnesses and brain tumors","volume":"82","author":"Pinna","year":"1997","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.lfs.2019.117080_bb0135","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1046\/j.1365-2265.2003.01697.x","article-title":"Increased serum reverse triiodothyronine levels at diagnosis of hepatocellular carcinoma in patients with compensated HCV-related liver cirrhosis","volume":"58","author":"Sorvillo","year":"2003","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.lfs.2019.117080_bb0140","doi-asserted-by":"crossref","first-page":"15549","DOI":"10.1074\/jbc.M115.649707","article-title":"Astrocyte elevated gene-1 (AEG-1) contributes to non-thyroidal illness syndrome (NTIS) associated with hepatocellular carcinoma (HCC)","volume":"290","author":"Srivastava","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2019.117080_bb0145","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1007\/s12672-014-0183-0","article-title":"Can non-thyroid illness syndrome predict mortality in lung cancer patients? A prospective cohort study","volume":"5","author":"Yasar","year":"2014","journal-title":"Horm Cancer"},{"key":"10.1016\/j.lfs.2019.117080_bb0150","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/nrcardio.2016.174","article-title":"Thyroid hormones and cardiovascular disease","volume":"14","author":"Jabbar","year":"2017","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.lfs.2019.117080_bb0155","doi-asserted-by":"crossref","unstructured":"Pingitore A., Nicolini G., Kusmic C., Iervasi G., Grigolini P., et al., Cardioprotection and thyroid hormones, Heart Failure Rev. 21 (2016) 391\u2013399. doi: https:\/\/doi.org\/10.1007\/s10741-016-9545-8.","DOI":"10.1007\/s10741-016-9545-8"},{"key":"10.1016\/j.lfs.2019.117080_bb0160","doi-asserted-by":"crossref","first-page":"900","DOI":"10.2119\/molmed.2015.00140","article-title":"Early and short-term triiodothyronine supplementation prevents adverse postischemic cardiac remodeling: role of transforming growth factor-\u03b21 and antifibrotic miRNA signaling","volume":"21","author":"Nicolini","year":"2016","journal-title":"Mol. Med."},{"key":"10.1016\/j.lfs.2019.117080_bb0165","doi-asserted-by":"crossref","unstructured":"Forini F., Nicolini G., Kusmic C., D'Aurizio R., Rizzo M., Baumgart M., et al., Integrative analysis of differentially expressed genes and miRNAs predicts complex T3-mediated protective circuits in a rat model of cardiac ischemia reperfusion, Sci. Rep. 8 (2018) 13870. doi: https:\/\/doi.org\/10.1038\/s41598-018-32237-0.","DOI":"10.1038\/s41598-018-32237-0"},{"key":"10.1016\/j.lfs.2019.117080_bb0170","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1161\/01.CIR.0000048124.64204.3F","article-title":"Low-T3 syndrome: a strong prognostic predictor of death in patients with heart disease","volume":"107","author":"Iervasi","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.lfs.2019.117080_bb0175","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1530\/JME-16-0118","article-title":"T3 enhances Ang2 in rat aorta in myocardial I\/R: comparison with left ventricle","volume":"57","author":"Sabatino","year":"2016","journal-title":"J. Mol. Endocrinol."},{"key":"10.1016\/j.lfs.2019.117080_bb0180","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1634\/theoncologist.2014-0308","article-title":"Medically induced euthyroid hypothyroxinemia may extend survival in compassionate need cancer patients: an observational study","volume":"20","author":"Hercbergs","year":"2015","journal-title":"Oncologist"},{"key":"10.1016\/j.lfs.2019.117080_bb0185","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1002\/jcp.10128","article-title":"Angiopoietin-2 plays an important role in retinal angiogenesis","volume":"192","author":"Hackett","year":"2002","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.lfs.2019.117080_bb0190","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1161\/CIRCRESAHA.106.143594","article-title":"Angiopoietin-2 impairs revascularization after limb ischemia","volume":"101","author":"Reiss","year":"2007","journal-title":"Circ. Res."},{"key":"10.1016\/j.lfs.2019.117080_bb0195","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1101\/sqb.2002.67.267","article-title":"Complementary and coordinated roles of the VEGFs and angiopoietins during normal and pathologic vascular formation","volume":"67","author":"Gale","year":"2002","journal-title":"Cold Spring Harb. Symp. Quant. Biol."},{"key":"10.1016\/j.lfs.2019.117080_bb0200","doi-asserted-by":"crossref","first-page":"5491","DOI":"10.1073\/pnas.0607538103","article-title":"Angiopoietin-2 functions as an autocrine protective factor in stressed endothelial cells","volume":"103","author":"Daly","year":"2006","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.lfs.2019.117080_bb0205","doi-asserted-by":"crossref","first-page":"4549","DOI":"10.1038\/sj.onc.1203800","article-title":"Angiopoietin-2 at high concentration can enhance endothelial cell survival through the phosphatidylinositol 3\u2032-kinase\/ Akt signal transduction pathway","volume":"19","author":"Kim","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.lfs.2019.117080_bb0210","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S0008-6363(00)00231-5","article-title":"Biological action of angiopoietin-2 in a fibrin matrix model of angiogenesis is associated with activation of Tie2","volume":"49","author":"Teichert-Kuliszewska","year":"2001","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.lfs.2019.117080_bb0215","doi-asserted-by":"crossref","first-page":"4564","DOI":"10.1172\/JCI74527","article-title":"Targeting VE-PTP activates TIE2 and stabilizes the ocular vasculature","volume":"124","author":"Shen","year":"2014","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.lfs.2019.117080_bb0220","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1128\/MCB.01472-08","article-title":"Angiopoietin 2 is a partial agonist\/antagonist of Tie2 signaling in the endothelium","volume":"29","author":"Yuan","year":"2009","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.lfs.2019.117080_bb0225","doi-asserted-by":"crossref","first-page":"3551","DOI":"10.1242\/jcs.03077","article-title":"Activation of Tie2 by angiopoietin-1 and angiopoietin-2 results in their release and receptor internalization","volume":"119","author":"Bogdanovic","year":"2006","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.lfs.2019.117080_bb0230","first-page":"87","article-title":"Angiopoietin-1\/Tie2 receptor signaling in vascular quiescence and angiogenesis","volume":"25","author":"Fukuhara","year":"2010","journal-title":"Histol. Histopathol."},{"key":"10.1016\/j.lfs.2019.117080_bb0235","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1073\/pnas.172161899","article-title":"Angiopoietin-2 displays VEGF-dependent modulation of capillary structure and endothelial cell survival in vivo","volume":"99","author":"Lobov","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.lfs.2019.117080_bb0240","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/ncb1714","article-title":"Differential function of Tie2 at cell-cell contacts and cell-substratum contacts regulated by angiopoietin-1","volume":"10","author":"Fukuhara","year":"2008","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.lfs.2019.117080_bb0245","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1161\/01.RES.86.1.24","article-title":"Angiopoietin-1 regulates endothelial cell survival through the phosphatidylinositol 3\u2019-kinase\/Akt signal transduction pathway","volume":"86","author":"Kim","year":"2000","journal-title":"Circ. Res."},{"key":"10.1016\/j.lfs.2019.117080_bb0250","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1101\/gad.1189704","article-title":"Angiopoietin-1 modulates endothelial cell function and gene expression via the transcription factor FKHR (FOXO1)","volume":"18","author":"Daly","year":"2004","journal-title":"Genes Dev."},{"key":"10.1016\/j.lfs.2019.117080_bb0255","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/nature16498","article-title":"FOXO1 couples metabolic activity and growth state in the vascular endothelium","volume":"529","author":"Wilhelm","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.lfs.2019.117080_bb0260","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.cytogfr.2013.05.009","article-title":"The angiopoietin:tie 2 interaction: a potential target for future therapies in human vascular disease","volume":"24","author":"Moss","year":"2013","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.lfs.2019.117080_bb0265","doi-asserted-by":"crossref","first-page":"3511","DOI":"10.1172\/JCI84871","article-title":"Opposing actions of angiopoietin-2 on Tie2 signaling and FOXO1 activation","volume":"126","author":"Kim","year":"2016","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.lfs.2019.117080_bb0270","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1083\/jcb.200411105","article-title":"Multiple angiopoietin recombinant proteins activate the Tie1 receptor tyrosine kinase and promote its interaction with Tie2","volume":"169","author":"Saharinen","year":"2005","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.lfs.2019.117080_bb0275","doi-asserted-by":"crossref","first-page":"3495","DOI":"10.1172\/JCI84923","article-title":"Tie1 controls angiopoietin function in vascular remodeling and inflammation","volume":"126","author":"Korhonen","year":"2016","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.lfs.2019.117080_bb0280","first-page":"1698","article-title":"A novel endothelial cell surface receptor tyrosine kinase with extracellular epidermal growth factor homology domains","volume":"12","author":"Partanen","year":"1992","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.lfs.2019.117080_bb0285","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1016\/j.celrep.2015.08.024","article-title":"The orphan receptor Tie1 controls angiogenesis and vascular remodeling by differentially regulating Tie2 in Tip and stalk cells","volume":"12","author":"Savant","year":"2015","journal-title":"Cell Rep."},{"key":"10.1016\/j.lfs.2019.117080_bb0290","doi-asserted-by":"crossref","first-page":"4025","DOI":"10.1182\/blood-2010-02-270819","article-title":"Identification and functional analysis of endothelial tip cell-enriched genes","volume":"116","author":"del Toro","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.lfs.2019.117080_bb0295","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1172\/JCI58832","article-title":"Angiopoietin-2 differentially regulates angiogenesis through TIE2 and integrin signaling","volume":"122","author":"Felcht","year":"2012","journal-title":"J. Clin Invest."},{"key":"10.1016\/j.lfs.2019.117080_bb0300","doi-asserted-by":"crossref","first-page":"26516","DOI":"10.1074\/jbc.M100282200","article-title":"Direct cell adhesion to the angiopoietins mediated by integrins","volume":"276","author":"Carlson","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2019.117080_bb0305","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.neures.2009.04.007","article-title":"Angiopoietin-1 induces neurite outgrowth of PC12 cells in a Tie2-independent, beta1-integrin-dependent manner","volume":"64","author":"Chen","year":"2009","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.lfs.2019.117080_bb0310","doi-asserted-by":"crossref","first-page":"5050","DOI":"10.1182\/blood-2011-03-343293","article-title":"Angiopoietin-2 promotes myeloid cell infiltration in a beta(2)-integrin-dependent manner","volume":"118","author":"Scholz","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.lfs.2019.117080_bb0315","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.2119\/molmed.2011.00106","article-title":"Angiopoietin-1 protects heart against ischemia\/reperfusion injury through VE-cadherin dephosphorylation and myocardiac integrin-\u03b21\/ERK\/caspase-9 phosphorylation cascade","volume":"17","author":"Lee","year":"2011","journal-title":"Mol. Med."},{"key":"10.1016\/j.lfs.2019.117080_bb0320","doi-asserted-by":"crossref","first-page":"5962","DOI":"10.1038\/ncomms6962","article-title":"Endothelial destabilization by angiopoietin-2 via integrin \u03b21 activation","volume":"6","author":"Hakanpaa","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.lfs.2019.117080_bb0325","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/nm.3798","article-title":"Understanding local macrophage phenotypes in disease: shape-shifting macrophages","volume":"21","author":"Liddiard","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.lfs.2019.117080_bb0330","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1182\/blood-2008-12-195941","article-title":"Hypoxia inducible factors 1 and 2 are important transcriptional effectors in primary macrophages experiencing hypoxia","volume":"114","author":"Fang","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.lfs.2019.117080_bb0335","doi-asserted-by":"crossref","first-page":"4696","DOI":"10.1038\/ncomms5696","article-title":"TSC1 controls macrophage polarization to prevent inflammatory disease","volume":"5","author":"Zhu","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.lfs.2019.117080_bb0340","doi-asserted-by":"crossref","first-page":"5018","DOI":"10.1172\/JCI99659","article-title":"Angiopoietin-2 exacerbates cardiac hypoxia and inflammation after myocardial infarction","volume":"128","author":"Lee","year":"2018","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.lfs.2019.117080_bb0345","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1002\/1097-0185(20000615)261:3<126::AID-AR7>3.0.CO;2-4","article-title":"Angiogenesis: new insights and therapeutic potential","volume":"261","author":"Tomanek","year":"2000","journal-title":"Anat. Rec."},{"key":"10.1016\/j.lfs.2019.117080_bb0350","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1093\/cvr\/cvu196","article-title":"Angiogenesis and remodelling in human thoracic aortic aneurysms","volume":"104","author":"Kessler","year":"2014","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.lfs.2019.117080_bb0355","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0066861","article-title":"Angiopoietin-2 in adults with congenital heart disease and heart failure","volume":"8","author":"Lukasz","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2019.117080_bb0360","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1172\/JCI119877","article-title":"Monocyte activation in angiogenesis and collateral growth in the rabbit hindlimb","volume":"101","author":"Arras","year":"1998","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.lfs.2019.117080_bb0365","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1161\/ATVBAHA.108.175463","article-title":"Angiopoietin-2 stimulates blood flow recovery after femoral artery occlusion by inducing inflammation and arteriogenesis","volume":"28","author":"Tressel","year":"2008","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.lfs.2019.117080_bb0370","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1124\/jpet.105.086553","article-title":"Angiopoietin-2 causes inflammation in vivo by promoting vascular leakage","volume":"314","author":"Roviezzo","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.lfs.2019.117080_bb0375","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1093\/eurjhf\/hft117","article-title":"Circulating angiopoietin-2, its soluble receptor Tie-2, and mortality in the general population","volume":"15","author":"Lorbeer","year":"2013","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.lfs.2019.117080_bb0380","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1093\/eurheartj\/ehs487","article-title":"Circulating angiopoietins and cardiovascular mortality in cardiogenic shock","volume":"34","author":"Link","year":"2013","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.lfs.2019.117080_bb0385","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1007\/s00392-014-0787-y","article-title":"Angiopoietin-2 and outcome in patients with acute decompensated heart failure","volume":"104","author":"P\u00f6ss","year":"2015","journal-title":"Clin. Res. Cardiol."},{"key":"10.1016\/j.lfs.2019.117080_bb0390","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1161\/01.ATV.0000116864.86607.35","article-title":"Angiopoietin 2 induces cell cycle arrest in endothelial cells: a possible mechanism involved in advanced plaque neovascularization","volume":"24","author":"Calvi","year":"2004","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.lfs.2019.117080_bb0395","first-page":"37","article-title":"Angiopoietins, abdominal aortic aneurysm and atherosclerosis","volume":"214","author":"Trollope","year":"2010","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.lfs.2019.117080_bb0400","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1136\/heartjnl-2014-306056","article-title":"Angiopoietin-2, its soluble receptor Tie-2 and subclinical cardiovascular disease in a population-based sample","volume":"101","author":"Lorbeer","year":"2015","journal-title":"Heart"},{"key":"10.1016\/j.lfs.2019.117080_bb0405","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1177\/1741826710389410","article-title":"Stepwise increase of angiopoietin-2 serum levels is related to haemodynamic and functional impairment in stable chronic heart failure","volume":"18","author":"Eleuteri","year":"2011","journal-title":"Eur. J. Cardiovasc. Prev. Rehabil."},{"key":"10.1016\/j.lfs.2019.117080_bb0410","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1159\/000112939","article-title":"Balance between angiopoietin-1 and angiopoietin-2 is in favor of angiopoietin-2 in atherosclerotic plaques with high microvessel density","volume":"45","author":"Post","year":"2008","journal-title":"J. Vasc. Res."},{"key":"10.1016\/j.lfs.2019.117080_bb0415","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.5114\/aoms.2016.62909","article-title":"Correlation between plasma angiopoietin-1, angiopoietin-2 and matrix metalloproteinase-2 in coronary heart disease","volume":"12","author":"Wu","year":"2016","journal-title":"Arch. Med. Sci."},{"key":"10.1016\/j.lfs.2019.117080_bb0420","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.atherosclerosis.2015.05.018","article-title":"Angiopoietin-2 blocking antibodies reduce early atherosclerotic plaque development in mice","volume":"241","author":"Theelen","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.lfs.2019.117080_bb0425","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000014216","article-title":"Prognostic value of angiopoietin-2 for patients with coronary heart disease after elective PCI","volume":"98","author":"Jian","year":"2019","journal-title":"Medicine"},{"key":"10.1016\/j.lfs.2019.117080_bb0430","doi-asserted-by":"crossref","first-page":"e107","DOI":"10.4172\/2167-1095.1000e107","article-title":"Angiopoietin-1, Angiopoietin-2 and myocardial ischemia-reperfusion injury","volume":"1","author":"Baoxia","year":"2012","journal-title":"J. Hypertens."},{"key":"10.1016\/j.lfs.2019.117080_bb0435","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1111\/ajt.12672","article-title":"Angiopoietin-2 inhibition prevents transplant ischemia-reperfusion injury and chronic rejection in rat cardiac allografts","volume":"14","author":"Syrj\u00e4l\u00e4","year":"2014","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.lfs.2019.117080_bb0440","doi-asserted-by":"crossref","first-page":"937","DOI":"10.3892\/etm.2013.893","article-title":"Association of serum angiopoietin-1, angiopoietin-2 and angiopoietin-2 to angiopoietin-1 ratio with heart failure in patients with acute myocardial infarction","volume":"5","author":"Chen","year":"2013","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.lfs.2019.117080_bb0445","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.ijcard.2016.03.005","article-title":"Prognostic value of angiopoietin-2 in patients with chronic heart failure","volume":"212","author":"Eleuteri","year":"2016","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.lfs.2019.117080_bb0450","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1007\/s40618-016-0502-0","article-title":"Angiopoietin-1 and Angiopoietin-2 in metabolic disorders: therapeutic strategies to restore the highs and lows of angiogenesis in diabetes","volume":"39","author":"Isidori","year":"2016","journal-title":"J. Endocrinol. Investig."},{"key":"10.1016\/j.lfs.2019.117080_bb0455","doi-asserted-by":"crossref","first-page":"H1003","DOI":"10.1152\/ajpheart.00866.2011","article-title":"Overexpression of angiopoietin-2 impairs myocardial angiogenesis and exacerbates cardiac fibrosis in the diabetic db\/db mouse model","volume":"302","author":"Chen","year":"2012","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.lfs.2019.117080_bb0460","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0135181","article-title":"Angiopoietin-2 as a Prognostic Biomarker of Major Adverse Cardiovascular Events and All-Cause Mortality in Chronic Kidney Disease","author":"Tsai","year":"2015","journal-title":"PLoS One10"},{"key":"10.1016\/j.lfs.2019.117080_bb0465","doi-asserted-by":"crossref","unstructured":"Tsai Y.C., Lee C.S., Chiu Y.W., Kuo H.T., Lee S.C., Hwang S.J., et al., Angiopoietin-2, Angiopoietin-1 and subclinical cardiovascular disease in Chronic Kidney Disease, Sci. Rep. 6 (2016) 39400. doi: https:\/\/doi.org\/10.1038\/srep39400.","DOI":"10.1038\/srep39400"},{"key":"10.1016\/j.lfs.2019.117080_bb0470","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0056273","article-title":"Circulating Angiopoietin-2 is a marker for early cardiovascular disease in children on chronic Dialysis","volume":"8","author":"Shroff","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2019.117080_bb0475","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1161\/ATVBAHA.116.308198","article-title":"Monocyte conversion during inflammation and injury","volume":"37","author":"Kratofil","year":"2017","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.lfs.2019.117080_bb0480","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1681\/ASN.2013050542","article-title":"Angiopoietin-2\u2013induced arterial stiffness in CKD","volume":"25","author":"Chang","year":"2014","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.lfs.2019.117080_bb0485","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1097\/HJH.0b013e32832be575","article-title":"Circulating angiopoietin-2 in essential hypertension: relation to atherosclerosis, vascular inflammation, and treatment with olmesartan\/pravastatin","volume":"27","author":"David","year":"2009","journal-title":"J. Hypertens."},{"key":"10.1016\/j.lfs.2019.117080_bb0490","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1080\/07853890701779586","article-title":"Angiopoietin-2 levels as a biomarker of cardiovascular risk in patients with hypertension","volume":"40","author":"Patel","year":"2008","journal-title":"Ann. Med."},{"key":"10.1016\/j.lfs.2019.117080_bb0495","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/j.1365-2796.2005.01550.x","article-title":"Abnormal angiopoietins 1&2, angiopoietin receptor Tie-2 and vascular endothelial growth factor levels in hypertension: relationship to target organ damage [a sub-study of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)]","volume":"258","author":"Nadar","year":"2005","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.lfs.2019.117080_bb0500","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1093\/cvr\/cvs124","article-title":"Angiopoietin-1 mediates inhibition of hypertension-induced release of angiopoietin-2 from endothelial cells","volume":"94","author":"Korff","year":"2012","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.lfs.2019.117080_bb0505","doi-asserted-by":"crossref","first-page":"5547","DOI":"10.1073\/pnas.0307574101","article-title":"COMP-Ang1: a designed angiopoietin-1 variant with nonleaky angiogenic activity","volume":"101","author":"Cho","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.lfs.2019.117080_bb0510","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1111\/j.1582-4934.2012.01593.x","article-title":"Thyroid hormone induces sprouting angiogenesis in adult heart of hypothyroid mice through the PDGF-Akt pathway","volume":"16","author":"Chen","year":"2012","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.lfs.2019.117080_bb0515","doi-asserted-by":"crossref","first-page":"12","DOI":"10.2174\/157340309787048158","article-title":"Thyroid hormone-induced angiogenesis","volume":"5","author":"Davis","year":"2009","journal-title":"Curr. Cardiol. Rev."},{"key":"10.1016\/j.lfs.2019.117080_bb0520","first-page":"1","article-title":"The stimulative effect of T3 and T4 on human myocardial endothelial cell proliferation, migration and angiogenesis","volume":"4","author":"Balzan","year":"2013","journal-title":"J. Clin. Exp. Cardiolog."},{"key":"10.1016\/j.lfs.2019.117080_bb0525","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1186\/1756-6614-4-S1-S6","article-title":"Transcriptional regulation by non classical action of thyroid hormone","volume":"4","author":"Moeller","year":"2011","journal-title":"Thyroid. Res."},{"key":"10.1016\/j.lfs.2019.117080_bb0530","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1210\/en.2005-1390","article-title":"Proangiogenesis action of the thyroid hormone analog 3,5-diiodothyropropionic acid (DITPA) is initiated at the cell surface and is integrin mediated","volume":"147","author":"Mousa","year":"2006","journal-title":"Endocrinol."},{"key":"10.1016\/j.lfs.2019.117080_bb0535","first-page":"C1014","article-title":"Thyroid hormone induces activation of mitogen activated protein kinase in cultured cells","volume":"276","author":"Lin","year":"1999","journal-title":"Am. J. Phys."},{"key":"10.1016\/j.lfs.2019.117080_bb0540","doi-asserted-by":"crossref","first-page":"2870","DOI":"10.1021\/bi001978b","article-title":"Thyroid hormone promotes serine phosphorylation of p53 by mitogen-activated protein kinase","volume":"40","author":"Shih","year":"2014","journal-title":"Biochemistry"},{"key":"10.1016\/j.lfs.2019.117080_bb0545","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1161\/01.RES.0000130784.90237.4a","article-title":"Proangiogenic action of thyroid hormone is fibroblast growth factor-dependent and is initiated at the cell surface","volume":"94","author":"Davis","year":"2004","journal-title":"Circ. Res."},{"key":"10.1016\/j.lfs.2019.117080_bb0550","doi-asserted-by":"crossref","unstructured":"Savinova O.V., Liu Y., Aasen G.A., Mao K., Weltman N.Y., Nedich B.L., et al., Thyroid hormone promotes remodeling of coronary resistance vessels, PLoS One 6 (2011) Article ID e25054. doi: https:\/\/doi.org\/10.1371\/journal.pone.0025054.","DOI":"10.1371\/journal.pone.0025054"},{"key":"10.1016\/j.lfs.2019.117080_bb0555","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/j.1582-4934.2010.01014.x","article-title":"Early long-term L-T3 replacement rescues mitochondria and prevents ischemic cardiac remodelling in rats","volume":"15","author":"Forini","year":"2011","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.lfs.2019.117080_bb0560","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1158\/1078-0432.CCR-09-1924","article-title":"Angiopoietin-2 promotes disease progression of neuroendocrine tumors","volume":"16","author":"Detjen","year":"2010","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.lfs.2019.117080_bb0565","first-page":"228","article-title":"Expression of angiopoietin-2 gene and its receptor Tie2 in hepatocellular carcinoma","volume":"21","author":"Chen","year":"2001","journal-title":"J. Tongji Med. Univ."},{"key":"10.1016\/j.lfs.2019.117080_bb0570","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1111\/j.1572-0241.2007.01377.x","article-title":"Angiopoietin-2 serum levels are elevated in patients with liver cirrhosis and hepatocellular carcinoma","volume":"102","author":"Scholz","year":"2007","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.lfs.2019.117080_bb0575","doi-asserted-by":"crossref","first-page":"272","DOI":"10.3346\/jkms.2006.21.2.272","article-title":"Expression of angiopoietin 1, 2 and their common receptor Tie2 in human gastric carcinoma: implication for angiogenesis","volume":"21","author":"Moon","year":"2006","journal-title":"J. Korean Med. Sci."},{"key":"10.1016\/j.lfs.2019.117080_bb0580","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1016\/S0002-9440(10)65088-2","article-title":"Expression of Tie1, Tie2, and angiopoietins 1, 2, and 4 in Kaposi\u2019s sarcoma and cutaneous angiosarcoma","volume":"156","author":"Brown","year":"2000","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.lfs.2019.117080_bb0585","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1158\/1078-0432.CCR-08-1615","article-title":"Angiopoietin-2 levels are associated with disease progression in metastatic malignant melanoma","volume":"15","author":"Helfrich","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.lfs.2019.117080_bb0590","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1038\/sj.bjc.6605925","article-title":"Identification of serum angiopoietin-2 as a biomarker for clinical outcome of colorectal cancer patients treated with bevacizumab-containing therapy","volume":"103","author":"Goede","year":"2010","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.lfs.2019.117080_bb0595","doi-asserted-by":"crossref","first-page":"353","DOI":"10.2147\/OTT.S119714","article-title":"Advances in antiangiogenic treatment of small-cell lung cancer","volume":"10","author":"Lu","year":"2017","journal-title":"Onco Targets Ther"},{"key":"10.1016\/j.lfs.2019.117080_bb0600","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/exd.12688","article-title":"Aggressive primary cutaneous B-cell lymphomas show increased Angiopoietin-2-induced angiogenesis","volume":"24","author":"Teichert","year":"2015","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.lfs.2019.117080_bb0605","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1053\/jhep.2002.32535","article-title":"Tie2 vascular endothelial receptor expression and function in hepatocellular carcinoma","volume":"35","author":"Tanaka","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.lfs.2019.117080_bb0610","doi-asserted-by":"crossref","first-page":"22399","DOI":"10.1073\/pnas.0911189106","article-title":"Embryonic stem cell tumor model reveals role of vascular endothelial receptor tyrosine phosphatase in regulating Tie2 pathway in tumor angiogenesis","volume":"106","author":"Li","year":"2009","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.lfs.2019.117080_bb0615","doi-asserted-by":"crossref","first-page":"8429","DOI":"10.1158\/0008-5472.CAN-07-1684","article-title":"Tie2-expressing monocytes and tumor angiogenesis: regulation by hypoxia and angiopoietin-2","volume":"67","author":"Lewis","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.lfs.2019.117080_bb0620","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1002\/hep.25965","article-title":"TIE2-expressing monocytes as a diagnostic marker for hepatocellular carcinoma correlates with angiogenesis","volume":"57","author":"Matsubara","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.lfs.2019.117080_bb0625","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.ccr.2005.08.002","article-title":"Sampaolesi, et al. Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors","volume":"8","author":"De Palma","year":"2005","journal-title":"Cancer Cell"},{"key":"10.1016\/j.lfs.2019.117080_bb0630","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1158\/1078-0432.CCR-10-2317","article-title":"Specifically targeting angiopoietin-2 inhibits angiogenesis, Tie2-expressing monocyte infiltration and tumor growth","volume":"17","author":"Huang","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.lfs.2019.117080_bb0635","doi-asserted-by":"crossref","first-page":"5679","DOI":"10.1158\/0008-5472.CAN-09-4446","article-title":"Recruitment of myeloid but not endothelial precursor cells facilitates tumor regrowth after local irradiation","volume":"70","author":"Kozin","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.lfs.2019.117080_bb0640","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1172\/JCI44562","article-title":"TIE2-expressing macrophages limit the therapeutic efficacy of the vascular-disrupting agent combretastatin A4 phosphate in mice","volume":"121","author":"Welford","year":"2011","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.lfs.2019.117080_bb0645","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nrclinonc.2018.29","article-title":"Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges","volume":"15","author":"Fukumura","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.lfs.2019.117080_bb0650","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1158\/0008-5472.CAN-09-1977","article-title":"Complementary actions of inhibitors of angiopoietin-2 and VEGF on tumor angiogenesis and growth","volume":"70","author":"Hashizume","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.lfs.2019.117080_bb0655","first-page":"25","article-title":"Targeting the Angiopoietin-2\/Tie-2 axis in conjunction with VEGF signal interference","volume":"3","author":"Biel","year":"2016","journal-title":"Cancer Lett."},{"key":"10.1016\/j.lfs.2019.117080_bb0660","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4236\/jct.2013.49A2001","article-title":"Combined Ang-2 and VEGF targeting therapies in renal cell carcinoma","volume":"4","author":"Molnar","year":"2013","journal-title":"J. Cancer Ther."},{"key":"10.1016\/j.lfs.2019.117080_bb0665","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1158\/1535-7163.MCT-09-0554","article-title":"A human monoclonal anti-ANG2 antibody leads to broad antitumor activity in combination with VEGF inhibitors and chemotherapy agents in preclinical models","volume":"9","author":"Brown","year":"2010","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.lfs.2019.117080_bb0670","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.celrep.2014.06.059","article-title":"Role of angiopoietin-2 in adaptive tumor resistance to VEGF signaling blockade","volume":"8","author":"Rigamonti","year":"2014","journal-title":"Cell Rep."},{"key":"10.1016\/j.lfs.2019.117080_bb0675","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.cell.2015.03.030","article-title":"Immune Checkpoint Targeting in Cancer Therapy: Toward Combination Strategies with Curative Potential","volume":"161","author":"Sharma","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.lfs.2019.117080_bb0680","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1158\/2326-6066.CIR-16-0206","article-title":"Angiopoietin-2 as a biomarker and target for immune checkpoint therapy","volume":"5","author":"Wu","year":"2017","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.lfs.2019.117080_bb0685","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1126\/science.284.5422.1994","article-title":"Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF","volume":"284","author":"Holash","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.lfs.2019.117080_bb0690","doi-asserted-by":"crossref","first-page":"39795","DOI":"10.18632\/oncotarget.7794","article-title":"Angiogenesis in NSCLC: is vessel co-option the trunk that sustains the branches?","volume":"8","author":"Coelho","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.lfs.2019.117080_bb0695","first-page":"186","article-title":"Surgical procedure as an inducer of tumor angiogenesis","volume":"32","author":"Kong","year":"2010","journal-title":"Exp. Oncol."},{"key":"10.1016\/j.lfs.2019.117080_bb0700","doi-asserted-by":"crossref","first-page":"12705","DOI":"10.18632\/oncotarget.24061","article-title":"Ang-2 promotes lung cancer metastasis by increasing epithelial-mesenchymal transition","volume":"9","author":"Dong","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.lfs.2019.117080_bb0705","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1016\/j.bbrc.2017.10.031","article-title":"Effect of Trichostatin A on radiation induced epithelial-mesenchymal transition in A549 cells","volume":"493","author":"Nagaraja","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.lfs.2019.117080_bb0710","doi-asserted-by":"crossref","unstructured":"Zhang Z., Yang Y., Zhang X., MiR-770 inhibits tumorigenesis and EMT by targeting JMJD6 and regulating WNT\/\u03b2catenin pathway in non-small cell lung cancer, Life Sci. 188 (2017)163\u2013171. doi: https:\/\/doi.org\/10.1016\/j.lfs.2017.09.002.","DOI":"10.1016\/j.lfs.2017.09.002"},{"key":"10.1016\/j.lfs.2019.117080_bb0715","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/cgt.2016.30","article-title":"Overexpression of angiopoietin 2 promotes the formation of oral squamous cell carcinoma by increasing epithelial-mesenchymal transition-induced angiogenesis","volume":"23","author":"Li","year":"2016","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.lfs.2019.117080_bb0720","first-page":"1699","article-title":"Regulation of epithelial-mesenchymal transition by tumor-associated macrophages in cancer","volume":"7","author":"Zhang","year":"2015","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.lfs.2019.117080_bb0725","doi-asserted-by":"crossref","first-page":"4057","DOI":"10.1038\/onc.2012.578","article-title":"Cancer-stromal cell interactions mediated by hypoxia-inducible factors promote angiogenesis, lymphangiogenesis and metastasis","volume":"32","author":"Semenza","year":"2013","journal-title":"Oncogene"},{"key":"10.1016\/j.lfs.2019.117080_bb0730","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3389\/fphys.2014.00075","article-title":"Role of tumor associated macrophages in tumor angiogenesis and lymphangiogenesis","volume":"5","author":"Riabov","year":"2014","journal-title":"Front. Physiol."},{"key":"10.1016\/j.lfs.2019.117080_bb0735","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1210\/jc.2017-01939","article-title":"Nonthyroidal illness syndrome and thyroid hormone actions at integrin avb3","volume":"103","author":"Hercbergs","year":"2018","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.lfs.2019.117080_bb0740","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0190179","article-title":"Restoration of type 1 iodothyronine deiodinase expression in renal cancer cells downregulates oncoproteins and affects key metabolic pathways as well as anti-oxidative system","volume":"12","author":"Pop\u0142awski","year":"2017","journal-title":"PLoS ONE"},{"key":"10.1016\/j.lfs.2019.117080_bb0745","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1158\/0008-5472.CAN-14-1875","article-title":"Antitumor responses stimulated by dendritic cells are improved by triiodothyronine binding to the thyroid hormone receptor \u03b2","volume":"75","author":"Alamino","year":"2015","journal-title":"Cancer Res."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320519310070?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320519310070?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T20:35:36Z","timestamp":1758400536000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320519310070"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":149,"alternative-id":["S0024320519310070"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2019.117080","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Angiopoietin 2 signal complexity in cardiovascular disease and cancer","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2019.117080","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"117080"}}